Clinical Trial Update: S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating S-1 and irinotecan combination chemotherapy for advanced gastric cancer; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Irinotecan (Camptosar) (Irinotecan)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Korean Cancer Study Group | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN